Kun-Ming Rau - Concepedia

Author

Kun-Ming Rau

Kaohsiung Chang Gung Memorial Hospital

Also Known As

Kun-Ming Rau

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Kaohsiung Chang Gung Memorial Hospital Chang Gung University Chang Gung Memorial Hospital Changhua Christian Hospital Mackay Memorial Hospital

About

Kun-Ming Rau is an author at Kaohsiung Chang Gung Memorial Hospital specializing in medicine, oncology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	562
2	Health Sciences	4	4	102
3	Public Health	2	2	56
4	Nursing	1	1	17
5	Family Medicine	1	1	34

Kun-Ming Rau

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy Heng‐Huan Lee, Ying‐Nai Wang, Weiya Xia, Cancer Cell MedicineImmunologyGlycobiologyPharmacotherapyCarbohydrate-protein Interaction	2019	387
Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors Jayesh Desai, Sanjeev Deva, Jong Seok Lee, Journal for ImmunoTherapy of Cancer	2020	145
Efficacy and Safety of the FOLFOX4 Regimen Versus Doxorubicin in Chinese Patients With Advanced Hepatocellular Carcinoma: A Subgroup Analysis of the EACH Study Shukui Qin, Ying Cheng, Jun Liang, The Oncologist	2014	98
Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: an open-label, multi-center, non-comparative phase II study Kun-Ming Rau, Yung‐Chang Lin, Yen-Yang Chen, BMC Cancer	2015	49
Impact of Undertreatment of Cancer Pain With Analgesic Drugs on Patient Outcomes: A Nationwide Survey of Outpatient Cancer Patient Care in Taiwan Wen-Chi Shen, Jen‐Shi Chen, Yu‐Yun Shao, Journal of Pain and Symptom Management Pain TherapyPain ResearchHealth SciencesMedicinePain Medicine	2017	43
Karnofsky Performance Status as A Predictive Factor for Cancer-Related Fatigue Treatment with Astragalus Polysaccharides (PG2) Injection—A Double Blind, Multi-Center, Randomized Phase IV Study Cheng‐Hsu Wang, Cheng-Yao Lin, Jen‐Shi Chen, Cancers Palliative CareOncologyPharmacologyKarnofsky Performance StatusAstragalus Polysaccharides Injection	2019	43
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression Baek‐Yeol Ryoo, Ann‐Lii Cheng, Zhenggang Ren, British Journal of Cancer	2021	39
Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinoma Yen-Hao Chen, Cheng-Hua Huang, Hung-I Lu, Journal of the Renin-Angiotensin-Aldosterone System	2014	37
Propensity for Home Death Among Taiwanese Cancer Decedents in 2001–2006, Determined by Services Received at End of Life Siew Tzuh Tang, Ean‐Wen Huang, Tsang-Wu Liu, Journal of Pain and Symptom Management Palliative CareFamily MedicineCancer EpidemiologyGeriatricsEnd-of-life Care	2010	34
Gender Difference in Cancer Patients’ Adherence to Analgesics and Related Outcomes of Pain Management Pi‐Ling Chou, Su‐Ying Fang, Jialing Sun, Cancer Nursing	2017	30

Page 1